Aeterna Zentaris and Consilient Health Launches Ghryvelin (macimorelin) Across the EU for the Diagnosis of Adult Growth Hormone De...
Shots: Ghryvelin (macimorelin) developed by Aeterna & its licensing partner, C...
Kala Entered into Definitive Agreement with Alcon to Acquire Eysuvis and Inveltys for the Treatment of Acute Dry Eye Disease
Shots: Kala will receive $60M up front along with additional fees upon achievement...
Evotec Collaborated with Almirall to Discover and Develop Novel Therapies for the Treatment of Skin Diseases
Shots: Evotec receives $241.23M up front, research fees & is eligible to recei...
Ultragenyx Entered into an Exclusive License Agreement with Abeona for ABO-102 (UX111) to Treat Sanfilippo Syndrome Type A
Shots: Abeona is eligible to receive commercial milestones along with royalties of...
MannKind Entered into an Agreement with Zealand to Acquire V-Go Insulin Delivery Device for the Treatment of Diabetes
Shots: The companies collaborated to acquire V-Go for $10M up front & an addit...
Evotec Collaborated with Sernova to Develop iPSC-Based Beta Cell Replacement Therapy for the Treatment of Diabetes
Shots: Evotec has invested $20.96M in Sernova & will contribute to cell manufa...
